Related by context. Frequent words. (Click for all words.) 64 Initiates Phase II 63 placebo controlled randomized 63 HGS ETR2 63 randomized multicenter 63 placebo controlled Phase 62 Initiate Phase 62 phase IIb clinical 61 Phase Ib clinical 61 refractory chronic lymphocytic 61 Phase III randomized 61 ongoing Phase 1b 61 Presents Positive 61 Phase Ib II 60 double blinded placebo 60 phase IIa clinical 60 Pivotal Phase III 60 Visit http:/www.Comtex.com 60 Commences Phase 59 Completes Enrollment 59 Phase 1b trial 59 PET FROM 59 randomized Phase III 59 report visit http:/www.aberdeen.com/link/sponsor.Rodrigo Santoro 59 blind randomized placebo 59 CA BUSINESS 59 Pivotal Phase 58 R sorafenib tablets 58 active comparator 58 dose escalation trial 58 Phase IIIb 58 phase Ib 58 By MICHAEL MORRISSEY 58 Receives Orphan Drug Designation 58 KRN# 58 multicenter randomized double 58 relapsed refractory multiple myeloma 58 JFAY@ENQUIRER.COM 57 Phase 2a clinical 57 multicenter prospective 57 Phase 1b clinical 57 multicenter Phase 57 plus prednisone 57 Pivotal Trial 57 AVADO 57 Bloomberg Correction Clarification 57 By DON BENEVENTO 57 primary hypercholesterolemia 57 Phase 2b clinical 57 HGS ETR1 57 randomized placebo controlled 57 teriflunomide 57 Entereg R 57 Copegus R 57 Phase 2a trial 57 placebo controlled clinical 57 phase IIb 57 ganetespib 57 CR# vcMMAE 56 forodesine 56 deforolimus 56 blind randomized controlled 56 By JIM FULLER 56 elotuzumab 56 phase IIa 56 sunitinib malate 56 multicenter randomized 56 Sym# 56 Phase Ib 56 metastatic castrate resistant 56 prospective multicenter 56 ThermoDox R 56 Microplasmin 56 safety tolerability pharmacokinetics 56 Carfilzomib 56 By SCOTT CACCIOLA 56 Clinical Trial Results 56 Azedra 56 subcutaneous formulation 56 PEG SN# 56 Denufosol 56 HALTS 56 Phase IIa trial 56 Ixempra 56 liposomal formulation 55 FDA Accepts 55 Phase IIa clinical 55 REVLIMID lenalidomide 55 Phase 2b 55 Metastatic Melanoma 55 PREZISTA r 55 prospective randomized controlled 55 IMC #B 55 phase 2a 55 multi kinase inhibitor 55 Phase 1b 55 Phase 2b study 55 eprotirome 55 thymalfasin 55 pharmacokinetic PK 55 II Clinical Trial 55 Initiates Phase